Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany-Reference-Cited by-同舟云学术

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany

Published:2012-11-22 Issue:6 Volume:91 Page:540-546
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:

Author:

Finger Robert P.,Wiedemann Peter,Blumhagen Francisca,Pohl Karin,Holz Frank G.

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2012.02493.x/fullpdf

Reference22 articles.

1. Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review;Bandukwala;Can J Ophthalmol,2010

2. Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment;Bloch;Acta Ophthalmol,2011

3. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration;Boyer;Ophthalmology,2007

4. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration;Boyer;Ophthalmology,2009

5. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration;Curtis;Arch Ophthalmol,2010

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration;Cochrane Database of Systematic Reviews;2024-06-03

2. Visual acuity prediction on real-life patient data using a machine learning based multistage system;Scientific Reports;2024-03-06

3. Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in Neovascular Age-related Macular Degeneration;Ophthalmology Science;2024-03

4. Characteristics of Patients Who Drop Out of Anti‐Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Branch Retinal Vein Occlusion;Journal of Ophthalmology;2024-01

5. Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial);Acta Ophthalmologica;2023-09-30